Animal health company presents vaccination data at veterinary conference

Animal health company MSD Animal Health will present data related to its swine products and service at the Sixth Asian Pig Veterinary Society (APVS) Congress on September 23-25, 2013 in Ho Chi Minh City, Vietnam. Attendees will be introduced to new data from Europe and Asia supporting the company's Porcilis PCV and Porcilis PRRS vaccines, covering various aspects on immunology and efficacy.

Animal health company MSD Animal Health will present data related to its swine products and service at the Sixth Asian Pig Veterinary Society (APVS) Congress on September 23-25, 2013 in Ho Chi Minh City, Vietnam. Attendees will be introduced to new data from Europe and Asia supporting the company's Porcilis PCV and Porcilis PRRS vaccines, covering various aspects on immunology and efficacy.

"The APVS Congress provides the ideal location to highlight key data related to the deadliest viruses that cause significant losses to the pig industry," said Rob Barclay, vice president of Asia Pacific MSD Animal Health. "Maintaining a healthy herd is vital to the Asian pig industry and we are committed to working with farmers to ensure the health and well-being of their animals."

Abstracts selected for oral and poster presentation represent advances in swine vaccination and herd health. The abstracts include the following:

Oral Presentations

  • Porcine Circovirus Type 2 Diagnostic Laboratory Trends: Relationship Between Year and Production Phase
  • Virological and Production Evaluation of Circumvent PCV M Administered During and Early Field Infection
  • Comparison of One- And Two-Dose Vaccines Against Porcine Circovirus Type 2 in Piglets
  • The Efficacy of A Type 1 PRRS Vaccine (Based on the Dv Strain) Tested in Piglets Under Field Conditions in Japan
  • Safety and Efficacy of Porcilis PRRS Vaccine in Vietnam
  • PRRS Stabilization in a High Pig Density Area, by Intradermal Mass-Vaccination (Porcilis PRRS) and Strict Biosecurity Measures
  • Synchronization of Estrus and Ovulation by an Altrenogest/Buserelin Treatment in Gilts Results in Good Fertility and Prolificacy Following a Single Fixed Time

Poster Presentations

  • A Safe and Efficacious MLV Vaccine can Contribute to the Control and Eradication of PRRSV
  • Benefits of Novel Intradermal Vaccination with a Modified Live Vaccine Against PRRS
  • Effect of MLV PRRSV (Porcilis PRRS) Vaccination in the Control of an Acute PRRS
  • Field Virus Infection in a Philippine Commercial Swine Farm
  • Presence of Both PRRS Type 1 and Type 2 Anitbiodies in Philippine Commercial Swine Farms
  • Comparison of Interleukin-10 Levels in Pigs Vaccinated with Modified Live PRRSV Vaccines of Type 1 and Type II Genotypes
  • Reduction of mortality and culling by the use of Porcilis PCV and/or Porcilis Glaesser
  • Laboratory Studies on Circumvent PCV M: Combination Mycoplasma Hyopneumoniae and Porcine Circovirus Type 2 Vaccine
  • Field Evaluation of Circumvent PCV M: Combination Mycoplasma Hyopneumoniae and Porcine Circovirus Type 2 Vaccine
  • Diagnostic Laboratory Survey of Porcine Circovirus Type 2 and Mycoplasma Hyopneumoniae Maternally-Derived Antibodies
  • Altering the PCV2 Vaccination Program as a Means of Improving Productivity
  • A Single Fixed Time Insemination Following Ovulation Induction by Buserelin Injection at 86 hours after Weaning in Sows Generates Good Fertility and Prolificacy
  • Evaluation Of The Benefits of AIAO/Batch Management System Implementation in Philippine Swine Farms
Page 1 of 51
Next Page